Search Results - "Baugher, Gary"

A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States by Fitz-Patrick, David, Young Jr, Mariano, Scott, Daniel A., Scully, Ingrid L., Baugher, Gary, Peng, Yahong, Jansen, Kathrin U., Gruber, William, Watson, Wendy

“…Expanding serotype coverage of pneumococcal conjugate vaccines (PCVs) to target prevailing disease-causing serotypes could further reduce disease burden. To…”
Get full text

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination by Cannon, Kevin, Elder, Charles, Young, Mariano, Scott, Daniel A., Scully, Ingrid L., Baugher, Gary, Peng, Yahong, Jansen, Kathrin U., Gruber, William C., Watson, Wendy

“…•A phase 3 study in adults ≥65 years of age with prior pneumococcal vaccination.•Safety and immunogenicity of PCV20 were described in this population.•PCV20…”
Get full text

A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants by Senders, Shelly, Klein, Nicola P, Tamimi, Noor, Thompson, Allison, Baugher, Gary, Trammel, James, Peng, Yahong, Giardina, Peter, Scully, Ingrid L, Pride, Michael, Center, Kimberly J, Gruber, William C, Scott, Daniel A, Watson, Wendy

“…The 20-valent pneumococcal conjugate vaccine (PCV20) was developed to extend pneumococcal disease protection beyond 13-valent PCV (PCV13). This phase 3,…”
Get full text

1728. Immune Responses to Cross-Reactive Serotypes 6C and 15C After 20-Valent Pneumococcal Conjugate Vaccine in Infants by Tamimi, Noor, Kline, Mary J, Center, Kimberly J, Thompson, Allison, Baugher, Gary, Drozd, Jelena, Scully, Ingrid L, Giardina, Peter, Trammel, James, Lei, Lanyu, Peng, Yahong, Scott, Daniel, Gruber, William C, Watson, Wendy

“…Abstract Background The 20-valent pneumococcal conjugate vaccine (PCV20) was developed to expand protection against pneumococcal disease. PCV20 contains…”
Get full text

16. A Randomized Phase 1 Study of a Novel Pneumococcal Conjugate Vaccine in Healthy Japanese Adults in the United States by Fitz-Patrick, David, Young Jr, Mariano, Scott, Daniel, Scully, Ingrid L, Baugher, Gary, Peng, Yahong, Jansen, Kathrin U, Gruber, William C, Watson, Wendy

“…Abstract Background Because of the number and variability of serotypes causing pneumococcal disease among different geographic regions, age groups, and…”
Get full text